Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suraxavir Marboxil (GP681) for Acute Uncomplicated Influenza
NCT05474755Phase 3Completed
- Sponsor
- Jiangxi Qingfeng Pharmaceutical Co. Ltd.
- Start
- Jul 2022
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of suraxavir marboxil in influenza, sponsored by Jiangxi Qingfeng Pharmaceutical Co. Ltd.. Started Jul 2022; status: completed.
02
Drugs
suraxavir marboxil
03
Conditions
influenza
Beyond the preview
Go deeper on NCT05474755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05474755.